Travere Therapeutics Inc
(TVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,903 | -39,300 | -2,187 | 11,216 | 117,237 |
| Depreciation Amortization | 17,888 | 13,297 | 8,850 | 4,443 | 19,840 |
| Income taxes - deferred | -22,661 | -10,999 | -12,286 | -5,070 | -15,573 |
| Accounts receivable | -6,090 | -2,544 | -4,153 | -927 | -4,504 |
| Accounts payable and accrued liabilities | -2,916 | 3,278 | 650 | -3,560 | 3,379 |
| Other Working Capital | 5,211 | 2,964 | -4,874 | -5,802 | -11,372 |
| Other Operating Activity | 53,030 | 38,356 | 14,423 | -3,867 | -110,396 |
| Operating Cash Flow | $-3,441 | $5,052 | $423 | $-3,567 | $-1,389 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -24,591 | -59,407 | -8,643 | -7,157 | -188,553 |
| PPE Investments | -1,428 | -61 | -24 | -24 | 148,389 |
| Net Acquisitions | -615 | -500 | -500 | N/A | -33,430 |
| Purchase Sale Intangibles | -10,496 | -7,632 | -4,881 | -2,575 | -7,008 |
| Other Investing Activity | 37,004 | 39,868 | -4,881 | -2,575 | -7,008 |
| Investing Cash Flow | $10,370 | $-20,100 | $-14,048 | $-9,756 | $-80,602 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,021 | 8,223 | 1,572 | 781 | 160,780 |
| Other Financing Activity | -13,870 | -7,028 | -4,415 | -1,707 | -59,178 |
| Financing Cash Flow | $-3,849 | $1,195 | $-2,843 | $-926 | $101,602 |
| Exchange Rate Effect | 117 | -57 | -182 | -294 | -10 |
| Beginning Cash Position | 37,805 | 37,805 | 37,805 | 37,805 | 18,204 |
| End Cash Position | 41,002 | 23,895 | 21,155 | 23,262 | 37,805 |
| Net Cash Flow | $3,197 | $-13,910 | $-16,650 | $-14,543 | $19,601 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,441 | 5,052 | 423 | -3,567 | -1,389 |
| Capital Expenditure | -1,428 | -61 | -24 | -24 | -22 |
| Free Cash Flow | -4,869 | 4,991 | 399 | -3,591 | -1,411 |